Topic prioritisation
Showing 241 to 250 of 379
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Circcurer Circumcision | None selected | Not selected | |
| Advanced pelvic exenteration / high complexity pelvic exenteration | None selected | Awaiting decision | |
| Macitentan for treating pulmonary arterial hypertension in people 1 month to 17 years [TSID11805] | None selected | Not selected | |
| O2Matic pro 100 (MT746) | None selected | Not selected | |
| Signatera molecular residual disease assay (MT741) | None selected | Not selected | |
| ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis [TSID11790] | None selected | Not selected | |
| DV7103 for treating cystinuria in people 6 months and over [TSID10438] | None selected | Further information required | |
| Polydioxanone stents for the therapy of Tracheal stenosis: adults | None selected | Awaiting decision | |
| Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ] | None selected | Not selected | |
| Canakinumab for untreated Schnitzler syndrome [ID4063] | None selected | Not selected |